Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | +1.41% | -12.12% | -22.04% |
04-22 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
04-12 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.04% | 5.76M | |
+31.12% | 49.46B | |
+1.11% | 42.58B | |
+49.00% | 42.49B | |
-5.26% | 29.09B | |
+12.73% | 26.61B | |
-23.76% | 18.64B | |
+7.24% | 13.16B | |
+31.35% | 12.55B | |
+23.77% | 12.1B |
- Stock Market
- Equities
- ADIL Stock
- News Adial Pharmaceuticals, Inc.
- Maxim Group Downgrades Adial Pharmaceuticals to Hold From Buy